Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 11, 2026
Rocket Lab (RKLB) Delivers Record Revenue but Misses EPS Target in Q2 2026

Rocket Lab (RKLB) Delivers Record Revenue but Misses EPS Target in Q2 2026

Key Takeaways

  • Record quarterly revenue of $234.07 million, up 62% year-over-year, narrowly surpassing consensus estimates of approximately $231.6 million.
  • GAAP loss per share of $0.08 missed the consensus estimate of a $0.06 loss, driven in part by acquisition-related transaction costs.
  • Backlog reached an all-time high of $2.36 billion, surging 137% from the year-ago period, with more than $1 billion in new contracts already signed in the first weeks of Q3.
  • Adjusted EBITDA loss narrowed to $8.8 million from $27.6 million a year earlier, significantly outperforming management's own guidance range.
  • Neutron rocket development remains on schedule for pad delivery in Q4 2026, though CEO Peter Beck noted the window for a year-end maiden launch is narrowing.
  • Shares declined roughly 2% to 6% in after-hours trading as the earnings miss and softer near-term margin guidance tempered enthusiasm around record top-line growth.

Why This Quarter Matters

Rocket Lab's Q2 2026 report arrives at a pivotal moment for the end-to-end space company. The stock had already pulled back roughly 45% from its May 2026 high near $151, reflecting broader investor re-pricing across high-growth, high-valuation space names. At more than 65 times trailing sales, Rocket Lab entered this earnings print with little room for error. The quarter also represents the first reporting period incorporating the closed acquisitions of Mynaric and Motiv, adding new revenue streams and cost dynamics. Meanwhile, the pending $8 billion acquisition of Iridium Communications — announced in June and expected to close in mid-2027 — continues to reshape the long-term narrative. Investors were scrutinizing whether Rocket Lab could sustain its remarkable growth trajectory while demonstrating a credible path toward profitability.

Q2 Results in Detail

Rocket Lab reported Q2 2026 revenue of $234.07 million, a 62% increase from $144.5 million in the same quarter last year and a new company record, exceeding the $231.6 million consensus estimate. Product revenue surged 96% year-over-year to $181.3 million, while service revenue contributed $52.7 million. Space Systems generated $189.5 million, and Launch Services added $44.6 million.

On the bottom line, the company posted a GAAP net loss of $49.3 million, or $0.08 per share, improving from a loss of $66.4 million, or $0.13 per share, a year earlier. However, the per-share result missed the consensus estimate of a $0.06 loss, with the gap largely attributable to $8.6 million in transaction costs tied to the Mynaric and Motiv acquisitions and the pending Iridium deal.

Profitability metrics showed encouraging momentum. Adjusted EBITDA loss narrowed sharply to $8.8 million from $27.6 million in Q2 2025, dramatically outperforming management's guidance range of a $20 million to $26 million loss. GAAP gross margin reached 36.1%, exceeding guidance of 33% to 35%, while non-GAAP gross margin of 41.5% surpassed the 38% to 40% guidance range. The company ended the quarter with $2.13 billion in cash and cash equivalents, providing substantial financial runway.

The backlog surged to a record $2.36 billion, up 137% year-over-year, with the launch backlog exceeding 90 missions — the highest in company history. Management disclosed that, combined with post-quarter signings, Rocket Lab has already booked more than $1 billion in new contracts across launch and space systems in Q3 to date.

From what I see, the backlog expansion stands out as particularly important because it signals sustained demand even as the company integrates recent acquisitions.

Market Reaction and Investor Sentiment

Despite delivering record revenue and backlog figures, Rocket Lab shares fell between 2% and 6% in after-hours trading on Monday. The decline reflected a mixed reception: while the top-line beat and order-book expansion validated the company's demand story, the wider-than-expected per-share loss and forward margin guidance disappointed investors conditioned to expect flawless execution at the stock's elevated valuation multiple.

Investor sentiment entering the print had been cautiously optimistic, with options market data showing a bullish skew and a put-to-call ratio of 0.58 on near-dated contracts. The stock had rallied more than 40% from its late-July lows ahead of the report. However, the after-hours slide suggests that for a company trading at over 65 times trailing revenue, even a record quarter can fall short of market expectations when profitability concerns persist. CEO Peter Beck's acknowledgment that the Neutron launch window is "narrowing" added an additional layer of uncertainty that likely contributed to the cautious post-earnings tone.

Forward Outlook and Key Factors to Monitor

Rocket Lab issued Q3 2026 revenue guidance of $250 million to $265 million — the midpoint of $257.5 million easily exceeding the analyst consensus of approximately $235.9 million and representing year-over-year growth of around 66%. This would mark the company's sixth consecutive record revenue quarter.

However, profitability guidance came in softer than anticipated. Management expects GAAP gross margins of 29% to 31% and non-GAAP gross margins of 35% to 37%, both below the Q2 results, reflecting a shift toward lower-margin satellite platform work. The adjusted EBITDA loss is projected at $17 million to $23 million — wider than some analysts had modeled. The sequential margin compression appears tied to product mix dynamics and continued investment in the Neutron program.

The Neutron medium-lift reusable rocket remains the single most important catalyst on the horizon. Stage 1 tank production is aligned with pad delivery in Q4 2026, and the Archimedes engine program has completed more than 400 hot-fire tests. Yet Beck's caution about the narrowing launch window introduces the real possibility that the maiden flight could slide into 2027. Any further timeline adjustments would likely weigh on sentiment, given that major contract wins — including the $397 million Space Force SB-AMTI award — depend on Neutron becoming operational.

Beyond Neutron, the Iridium acquisition looms as a transformative event. Expected to close in mid-2027, the deal would add an operational 66-satellite constellation, over 2.5 million subscribers, and more than $870 million in annual revenue, positioning Rocket Lab as a vertically integrated space communications provider. Meanwhile, investors should monitor backlog conversion rates, the ramp-up of GHOST containerized launch operations in Alaska by 2027, and the integration of Mynaric and Motiv, which are expected to expand the company's space systems capabilities.

I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.

AI Tools in My Research Workflow

In my analysis of high-growth sectors like aerospace, I often turn to Tickeron's AI-powered platforms to cross-reference fundamentals and technical signals. One tool that has proven useful is the AI Trend Prediction Engine, which helps surface potential momentum shifts based on historical patterns and current data. These resources allow me to quickly validate ideas without sifting through endless spreadsheets, keeping the focus on what actually moves the needle for long-term positioning.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RKLB

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


RKLB in -4.31% downward trend, falling for three consecutive days on August 21, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RKLB declined for three days, in of 288 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RKLB broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RKLB entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RKLB's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for RKLB just turned positive on July 31, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.280) is normal, around the industry mean (7.037). P/E Ratio (0.000) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (55.249) is also within normal values, averaging (20.174).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
RKLB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
3881 McGowen Street
Phone
+1 714 465-5737
Employees
2600
Web
https://www.rocketlabusa.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.